Our strategy

Better business with biology

Shaped by the promise of biology, we step into a future of better business – for customers, for Novozymes and for the world.

Focus areas

Reallocate toward high-impact innovation

Expand emerging-market and commercial activity

Simplify, optimize and digitize

Thrive in a dynamic organization

Mid-term targets, 2020-2022

Measuring our success

By working together with customers,  partners, politicians and citizens, we  measure the progress of our strategy on the following targets
Measuring our success

World

Novozymes is committed to help solving three global challenges: Climate, Water and sustainable Production & Consumption

CLIMATE 

Save 60 million tons CO2
by enabling low-carbon fuels in the  transport sector in 2022.

WATER

Reach >4 billion people
by providing laundry solutions that replace chemicals in 2022

PRODUCTION & CONSUMPTION

Gain 500,000 tons of food
by improving efficiency from farm to table in 2022

Measuring our success

Business

We have three financial targets: Organic sales growth, EBIT margin and ROIC incl. goodwill
Green squash plant

Organic sales growth
5+% per year

2020 will likely be negatively impacted
by portfolio changes

EBIT margin
28% or above by 2022
ROIC incl. goodwill
23% or above by 2022
Measuring our success

Zymers

To continue to grow and contribute to a better world, we will enable Zymers to thrive, grow and perform. This ensures that we have the skills needed to deliver on our purpose. We will measure our ability to reach the full potential of Zymers through four specific targets
lightbulb
Enable learning
80 on learning in employee survey in 2022
Nurture diversity
86 on our diversity index by 2022
Ensure wellbeing
Improve safety by reducing the number of accidents by 2022
Inspire the world
Pledge 1% of our time to local outreach activities by 2022

Explore our 2018 Report 

Learn about our results, business model, targets, outlook and so much more
History

Our story in brief

2000

While our roots stretch back to the foundation of Novo Terapeutisk Laboratorium in 1925, our story really began in 2000 when Novo was split into three independent companies:  Novo A/S, Novo Nordisk A/S, and Novozymes A/S.  We already had a strong portfolio of enzymes at this point, especially for the Food & Beverages and Household Care industries.

Consumers shopping in San Diego

2001 – 2011

A number of acquisitions strengthened our business in the bioagriculture sector. In the same decade, we inaugurated the world’s largest enzyme fermentation facility in China.

Betarenewables biorefinery in Italy

2011 - 2013

Following the opening of the world’s first commercial-scale cellulosic ethanol plant in Crescentino, Italy, using Novozymes enzymes, the commercial production of cellulosic ethanol continued to broaden globally. In 2012 we inaugurated a plant of our own to produce biofuel enzymes in Nebraska. We now provide enzymatic solutions to the biofuel industry in South and North America and Europe.

Harvesting corn in Iowa, US.

2014 - today

The BioAg Alliance - formed with Monsanto in 2013 to develop more sustainable solutions for farmers - became fully operational. We also began to work with Adisseo and Boehringer Ingelheim Animal Health on probiotics as a sustainable potential alternative to antibiotic growth promoters in animal feed. In 2017, the application of our products helped reduce CO2 emissions by an estimated 76 million tons, and the Dow Jones Sustainability Index ranked us among the top 6% of companies in the chemical industry sector.

Peanut field in North Carolina

Positions & Policies

Position papers cover Novozymes’ view on issues that our stakeholders find particularly important. Policies describe how we will conduct our daily work in support of Novozymes' purpose and values.  

Ownership and management

Novozymes’ stock consists of two types: A and B shares. Both shares have a nominal value of DKK 2 per share, but an A share carries 10 times as many votes as a B share. Management in Novozymes A/S, the parent company, is headed by Novozymes' Board of Directors and the Executive Leadership Team